• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Enforcement Report - Week of November 29, 2023

    FDA

    Exela Pharma Sciences, LLC Issues Voluntary Nationwide Recall of 8.4% Sodium Bicarbonate Injection, USP, 50 mEq/50 mL, Midazolam in 0.8% Sodium Chloride Injection 100 mg/100 mL, and ELCYS (cysteine hydrochloride Injection), USP 500 mg/10 mL Due to the Presence of Particulate Matter

    FDA

    Eton Pharmaceuticals Announces FDA Approval of Cysteine Hydrochloride Injection

    GLOBENEWSWIRE

    Eton Pharma`s Generic Cysteine Hydrochloride Receives Approval in US

    FDA

    Eton Pharma Confirms First-to-File Patent Challenge on Elcys

    GLOBENEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.